CD19 CAR T-cells effective with with low dose chemotherapy.
CD19 CAR T-cells effective with with low dose chemotherapy.
Specific mutations in leukaemia patients' blood predicts survival
Causes and consequences of microRNA dysregulation in cancer
Sequencing multiple myeloma reveals a complex landscape of genetic lesions
Results from SCHOLAR-1 trial for DLBCL patients
PD-1 enhances elotuzumab efficacy
Novel therapies for older patients with AML and MDS
Better screening programmes needed for haematological malignancies such as leukaemia
Karyotyping a CLL subset with ibrutinib susceptibility
The role of AKT in chronic lymphocytic leukaemia transformation to Richter's syndrome
Advances in first line treatment options for MCL patients
Targeted genome editing in haematopoeitic stem cells